RSS   Newsletter   Contact   Advertise with us
Post Online Media

Syndax Pharma appoints Pierre Legault to board

Syndax PharmaceuticalsSyndax Pharmaceuticals, a late-stage biopharmaceutical company, announced the appointment of Pierre Legault to its board of directors.

Mr. Legault currently serves on the board of Poxel Pharmaceuticals, Iroko Pharmaceuticals and NephroGenex, and he most recently served as board member, chairman, and audit chair, respectively.

Mr. Legault serves on the compensation and other committees, of several leading companies that were successfully acquired, notably, NPS Pharmaceuticals, Forest Laboratories, Eckerd Pharmacy and Tobira Therapeutics.

Mr. Legault’s prior executive experience includes serving as Chief Executive Officer, President, Chief Administrative Officer and Chief Financial Officer of several public companies such as Eckerd Pharmacy, OSI Pharmaceuticals, Prosidion, Ltd, and Rite Aid.

He has also held several senior positions with Sanofi-Aventis and predecessor companies, including President of Worldwide Dermatology Operations.

Mr. Legault studied at McGill University, University of Montreal (HEC), and Harvard Business School, and holds a Six Sigma Green Belt, a BAA, MBA, CA and CPA diploma.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy